Mohsen Sadatsafavi

13.9k total citations · 4 hit papers
233 papers, 8.1k citations indexed

About

Mohsen Sadatsafavi is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Economics and Econometrics. According to data from OpenAlex, Mohsen Sadatsafavi has authored 233 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Pulmonary and Respiratory Medicine, 91 papers in Physiology and 37 papers in Economics and Econometrics. Recurrent topics in Mohsen Sadatsafavi's work include Asthma and respiratory diseases (78 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (71 papers) and Health Systems, Economic Evaluations, Quality of Life (31 papers). Mohsen Sadatsafavi is often cited by papers focused on Asthma and respiratory diseases (78 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (71 papers) and Health Systems, Economic Evaluations, Quality of Life (31 papers). Mohsen Sadatsafavi collaborates with scholars based in Canada, United States and United Kingdom. Mohsen Sadatsafavi's co-authors include J. Mark FitzGerald, J. Antonio Aviña‐Zubieta, Diane Lacaille, Jamie M. Thomas, Wenjia Chen, Mahyar Etminan, Carlo A. Marra, John M. Esdaile, Larry D. Lynd and Hyon K. Choi and has published in prestigious journals such as The Lancet, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Mohsen Sadatsafavi

214 papers receiving 7.9k citations

Hit Papers

Risk of cardiovascular mortality in patients with rheumat... 2008 2026 2014 2020 2008 2010 2012 2015 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta‐analysis of observational studies
    2008 1.1k citations Mohsen Sadatsafavi, John M. Esdaile et al. profile →
  2. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial
    2010 989 citations Mohsen Sadatsafavi, Carlo A. Marra et al. profile →
  3. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies
    2012 727 citations Mohsen Sadatsafavi et al. profile →
  4. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
    2015 443 citations Wenjia Chen, Mohsen Sadatsafavi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohsen Sadatsafavi Canada 38 2.7k 2.0k 1.4k 1.2k 1.2k 233 8.1k
Tebeb Gebretsadik United States 47 1.4k 0.5× 1.2k 0.6× 1.5k 1.1× 730 0.6× 2.3k 2.0× 169 7.8k
Karen M. Kuntz United States 65 3.2k 1.2× 1.4k 0.7× 1.1k 0.8× 1.8k 1.5× 2.0k 1.6× 243 16.1k
Nicola J. Cooper United Kingdom 44 1.6k 0.6× 613 0.3× 651 0.5× 780 0.6× 1.6k 1.3× 143 10.5k
Angela C Webster Australia 63 1.9k 0.7× 767 0.4× 467 0.3× 1.1k 0.9× 3.2k 2.7× 298 15.6k
Corinne Alberti France 58 2.8k 1.0× 692 0.3× 343 0.2× 683 0.6× 2.9k 2.4× 283 12.4k
Doug Coyle Canada 51 767 0.3× 1.2k 0.6× 603 0.4× 1.1k 0.9× 1.0k 0.9× 298 10.7k
Paul C. Lambert United Kingdom 53 1.6k 0.6× 1.0k 0.5× 425 0.3× 715 0.6× 1.6k 1.4× 225 12.8k
Andrew R. Willan Canada 61 3.0k 1.1× 1.6k 0.8× 541 0.4× 2.1k 1.8× 1.8k 1.5× 264 17.4k
Jacques Bénichou France 52 2.2k 0.8× 678 0.3× 1.1k 0.8× 379 0.3× 1.2k 1.0× 231 10.2k
Tjeerd van Staa United Kingdom 71 1.9k 0.7× 1.4k 0.7× 2.2k 1.6× 1.4k 1.1× 3.5k 2.9× 337 23.1k

Countries citing papers authored by Mohsen Sadatsafavi

Since Specialization
Citations

This map shows the geographic impact of Mohsen Sadatsafavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohsen Sadatsafavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohsen Sadatsafavi more than expected).

Fields of papers citing papers by Mohsen Sadatsafavi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohsen Sadatsafavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohsen Sadatsafavi. The network helps show where Mohsen Sadatsafavi may publish in the future.

Co-authorship network of co-authors of Mohsen Sadatsafavi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohsen Sadatsafavi. A scholar is included among the top collaborators of Mohsen Sadatsafavi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohsen Sadatsafavi. Mohsen Sadatsafavi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sadatsafavi, Mohsen, et al.. (2025). Expected Value of Sample Information Calculations for Risk Prediction Model Validation. Medical Decision Making. 45(3). 232–244. 1 indexed citations
2.
Yin, Yiwei, et al.. (2025). Temporal trends and regional variations in the burden of chronic obstructive pulmonary disease. Canadian Journal of Respiratory Critical Care and Sleep Medicine. 9(6). 287–295.
3.
Hossain, Md. Belal, Hubert Wong, Mohsen Sadatsafavi, et al.. (2024). Benefits of Repeated Matched-Cohort and Nested Case–Control Analyses with Time-dependent Exposure in Observational Studies. Statistics in Biosciences. 17(3). 709–737. 1 indexed citations
4.
Minh, Huynh Van, Peter Loewen, Mohsen Sadatsafavi, et al.. (2024). Pharmacotherapy sequencing strategies for patients with heart failure with reduced ejection fraction: a cost–utility analysis. Canadian Medical Association Journal. 196(36). E1221–E1231.
5.
Sadatsafavi, Mohsen & John Petkau. (2024). Non‐parametric inference on calibration of predicted risks. Statistics in Medicine. 43(18). 3524–3538. 1 indexed citations
6.
Pataky, Reka, Stuart Peacock, Stirling Bryan, Mohsen Sadatsafavi, & Dean A. Regier. (2024). Using Genomic Heterogeneity to Inform Therapeutic Decisions for Metastatic Colorectal Cancer: An Application of the Value of Heterogeneity Framework. Applied Health Economics and Health Policy. 23(3). 441–452. 1 indexed citations
7.
Pataky, Reka, Stirling Bryan, Mohsen Sadatsafavi, Stuart Peacock, & Dean A. Regier. (2023). Real-World Cost Effectiveness of a Policy of KRAS Testing to Inform Cetuximab or Panitumumab for Third-Line Therapy of Metastatic Colorectal Cancer in British Columbia, Canada. PharmacoEconomics - Open. 7(6). 997–1006. 2 indexed citations
8.
Gao, Zhiwei, Jennifer K Quint, Richard Russell, et al.. (2023). QRISK3 underestimates the risk of cardiovascular events in patients with COPD. Thorax. 79(8). 718–724. 13 indexed citations
9.
Hossain, Md. Belal, James C. Johnston, Victoria Cook, et al.. (2023). Role of latent tuberculosis infection on elevated risk of cardiovascular disease: a population-based cohort study of immigrants in British Columbia, Canada, 1985–2019. Epidemiology and Infection. 151. e68–e68. 7 indexed citations
10.
Kendzerska, Tetyana, David T. Zhu, Michael Pugliese, et al.. (2023). Trends in outpatient and inpatient visits for separate ambulatory-care-sensitive conditions during the first year of the COVID-19 pandemic: a province-based study. Frontiers in Public Health. 11. 1251020–1251020. 1 indexed citations
11.
Adibi, Amin, Stuart E. Turvey, Malcolm R. Sears, et al.. (2021). Development of a conceptual model of childhood asthma to inform asthma prevention policies. BMJ Open Respiratory Research. 8(1). e000881–e000881. 2 indexed citations
12.
Sadatsafavi, Mohsen, Jolene H. Fisher, Julie Morisset, et al.. (2019). Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung Disease. CHEST Journal. 156(5). 887–895. 15 indexed citations
13.
Tavakoli, Hamid, KATE JOHNSON, J Mark FitzGerald, et al.. (2019). <p>Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada</p>. International Journal of COPD. Volume 14. 2003–2013. 18 indexed citations
14.
Ryerson, Christopher J., Charlene D. Fell, H. Manganas, et al.. (2016). The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry. Canadian Respiratory Journal. 2016. 1–7. 34 indexed citations
15.
To, Teresa, Jingqin Zhu, Kristian Larsen, et al.. (2016). Progression from Asthma to Chronic Obstructive Pulmonary Disease. Is Air Pollution a Risk Factor?. American Journal of Respiratory and Critical Care Medicine. 194(4). 429–438. 101 indexed citations
16.
Sadatsafavi, Mohsen, Carlo A. Marra, Shawn D. Aaron, & Stirling Bryan. (2014). Incorporating external evidence in trial-based cost-effectiveness analyses: the use of resampling methods. Trials. 15(1). 201–201. 5 indexed citations
17.
Aviña-Zubieta, Antonio, Mohsen Sadatsafavi, Eric C. Sayre, & John M. Esdaile. (2014). Elevated risk of chronic obstructive pulmonary disease in systemic lupus erythematosus: a population-based study. Arthritis Research & Therapy. 16(S1). 1 indexed citations
18.
Gan, Wenqi, J. Mark FitzGerald, Chris Carlsten, Mohsen Sadatsafavi, & Michael Bräuer. (2013). Associations of Ambient Air Pollution with Chronic Obstructive Pulmonary Disease Hospitalization and Mortality. American Journal of Respiratory and Critical Care Medicine. 187(7). 721–727. 222 indexed citations
19.
20.
Bedouch, Pierrick, Carlo A. Marra, J. Mark FitzGerald, Larry D. Lynd, & Mohsen Sadatsafavi. (2012). Trends in Asthma-Related Direct Medical Costs from 2002 to 2007 in British Columbia, Canada: A Population Based-Cohort Study. PLoS ONE. 7(12). e50949–e50949. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tebeb Gebretsadik Breakdown of academic impact, for papers by Karen M. Kuntz Breakdown of academic impact, for papers by Nicola J. Cooper Breakdown of academic impact, for papers by Angela C Webster Breakdown of academic impact, for papers by Corinne Alberti Breakdown of academic impact, for papers by Doug Coyle Breakdown of academic impact, for papers by Paul C. Lambert Breakdown of academic impact, for papers by Andrew R. Willan Breakdown of academic impact, for papers by Jacques Bénichou Breakdown of academic impact, for papers by Tjeerd van Staa
Rankless by CCL
2026